The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The usual care arm in this study included pharmacists who did not make medication changes, suggesting that the inclusion of pharmacists or other nonphysician team members in diabetes care teams is not sufficient to improve diabetes outcomes; those team members must also be empowered to implement guideline-based medication changes.”
From Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis (2021) · cites this paper as [13]
In the citing paper
“The most effective approaches to mitigating therapeutic inertia and improving HbA1c identified in our study were those interventions where nonphysician providers such as pharmacists, nurses and CDEs had autonomy to address therapeutic inertia in partnership with primary care providers.13,23,29,30,37,44,48”
From Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis (2021) · cites this paper as [13]
In the citing paper
“The usual care arm in this study included pharmacists who did not make medication changes, suggesting that the inclusion of pharmacists or other nonphysician team members in diabetes care teams is not sufficient to improve diabetes outcomes; those team members must also be empowered to implement guideline-based medication changes.”
From Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis (2021) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
Pharmacist Interventions to Improve Cardiovascular Disease Risk Factors in Diabetes
Santschi, V., Chiolero, A., Paradis, G., Colosimo, A. L., & Burnand, B. (2012) · Diabetes Care · doi:10.2337/dc12-0369 · Cited by 145
Research works printed but not linked: 21
- Diabetes Canada, 2013, 2013 clinical practice guidelines, Can J Diabetes, 37, S1
- Lam, 2015, Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing, World J Diabetes, 6, 634, 10.4239/wjd.v6.i4.634 · DOI
- Grenier, 2016, Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: Insights from the diabetes mellitus status in Canada survey, Eur Heart J Qual Care Clin Outcomes, 2, 277, 10.1093/ehjqcco/qcw013 · DOI
- Shiu, 2006, Quantifying opportunities to affect diabetes management in the community, Can Pharm J, 139, 37
- Al Hamarneh, 2013, Pharmacist intervention for glycaemic control in the community (The RxING study), BMJ Open, 3, e003154, 10.1136/bmjopen-2013-003154 · DOI
- O'Donovan, 2011, The role of pharmacists in control and management of type 2 diabetes mellitus: A review of the literature, J Diabetol, 1, 5
- Wubben, 2008, Effects of pharmacist outpatient interventions on adults with diabetes mellitus: A systematic review, Pharmacotherapy, 28, 421, 10.1592/phco.28.4.421 · DOI · Paper page
- Armour, 2004, Implementation and evaluation of Australian pharmacists' diabetes care services, J Am Pharm Assoc, 44, 455, 10.1331/1544345041475625 · DOI
- Fornos, 2006, A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain, Pharm World Sci, 28, 65, 10.1007/s11096-006-9003-0 · DOI
- Krass, 2007, The pharmacy diabetes care program: Assessment of a community pharmacy diabetes service model in Australia, Diabet Med, 24, 677, 10.1111/j.1464-5491.2007.02143.x · DOI · Paper page
- Al Hamarneh, 2012, Glycemic control in community-dwelling patients with type 2 diabetes, Can Pharm J, 2, 68, 10.3821/145.2.cpj68 · doi:10.3821/145.2.cpj68
- Leiter, 2013, Type 2 diabetes mellitus management in Canada: Is it improving?, Can J Diabetes, 37, 82, 10.1016/j.jcjd.2013.02.055 · DOI
- Tsuyuki, 2016, Effectiveness of community pharmacist prescribing and care on cardiovascular risk reduction: Randomized controlled RxEACH trial, J Am CollCardiol, 67, 2846, 10.1016/j.jacc.2016.03.528 · DOI · Paper page
- Leung, 2016, Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension, Can J Cardiol, 32, 569
- Hackam, 2013, The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension, Can J Cardiol, 29, 528
- Anderson, 2013, 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult, Can J Cardiol, 29, 151
- Tobe, 2011, Harmonization of guidelines for the prevention and treatment of cardiovascular: The C-CHANGE initiative, CMAJ, 183, e1135, 10.1503/cmaj.101508 · DOI
- D'Agostino, 2008, General cardiovascular risk profile for use in primary care: The Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579 · DOI · Paper page
- Wilson, 2012, An international model to predict recurrent cardiovascular disease, Am J Med, 125, 695, 10.1016/j.amjmed.2012.01.014 · DOI · Paper page
- Song, 2004, Coronary heart disease risk assessment in diabetes mellitus: Comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications, Diabet Med, 21, 238, 10.1111/j.1464-5491.2004.01116.x · DOI · Paper page
- Martinez, 2017, Frequency and impact of pharmacist interventions in clinical trial patients with diabetes, Clin Ther, 39, 714, 10.1016/j.clinthera.2017.02.006 · doi:10.1016/j.clinthera.2017.02.006
Cited by
Powell, R. E., Zaccardi, F., Beebe, C., Chen, X. M., Crawford, A., Cuddeback, J., Gabbay, R. A., Kissela, L., Litchman, M. L., Mehta, R., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14455 · Cited by 99
“For example, in an RCT by Al Hamarneh et al,13 patients were randomized either to an intervention arm which received medication therapy management consultations with pharmacists, or to usual care by primary care physicians and pharmacists.”
BackgroundMethodInfluential
Metadata
- Authors
- Al Hamarneh, Y. N., Hemmelgarn, B. R., Hassan, I., Jones, C. A., & Tsuyuki, R. T.
- Venue
- Canadian Journal of Diabetes
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 41
- Issue
- 6
- Pages
- 580-586
- ISSN
- 1499-2671
- Cited by
- 36
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- RxEACH-CKD: Alberta Health (RES0020309)
- The Cardiovascular Health and Stroke Strategic Clinical Network of Alberta Health Services (RES0027161)
- Merck Canada (RES0019426)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial. https://app.cochat.ai/papers/10.1016/j.jcjd.2017.08.244
- The paper
- Al Hamarneh, Y. N., Hemmelgarn, B. R., Hassan, I., Jones, C. A., & Tsuyuki, R. T. (2017). The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial. Canadian Journal of Diabetes. https://doi.org/10.1016/j.jcjd.2017.08.244
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.